BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11753645)

  • 1. The HPV-16 E7 oncoprotein binds Skip and suppresses its transcriptional activity.
    Prathapam T; Kühne C; Banks L
    Oncogene; 2001 Nov; 20(52):7677-85. PubMed ID: 11753645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of the human papillomavirus type 16 E7 oncoprotein and the adeno-associated virus Rep78 major regulatory protein in vitro and in yeast and the potential for downstream effects.
    Hermonat PL; Santin AD; Zhan D
    J Hum Virol; 2000; 3(3):113-24. PubMed ID: 10881991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus-16 E7 protein inhibits the DNA interaction of the TATA binding transcription factor.
    Maldonado E; Cabrejos ME; Banks L; Allende JE
    J Cell Biochem; 2002; 85(4):663-9. PubMed ID: 11968006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the HPV E7 proteins with the pCAF acetyltransferase.
    Avvakumov N; Torchia J; Mymryk JS
    Oncogene; 2003 Jun; 22(25):3833-41. PubMed ID: 12813456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ski interacts with the evolutionarily conserved SNW domain of Skip.
    Prathapam T; Kühne C; Hayman M; Banks L
    Nucleic Acids Res; 2001 Sep; 29(17):3469-76. PubMed ID: 11522815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein.
    Brokaw JL; Yee CL; Münger K
    Virology; 1994 Dec; 205(2):603-7. PubMed ID: 7975265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300.
    Patel D; Huang SM; Baglia LA; McCance DJ
    EMBO J; 1999 Sep; 18(18):5061-72. PubMed ID: 10487758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ski oncoprotein interacts with Skip, the human homolog of Drosophila Bx42.
    Dahl R; Wani B; Hayman MJ
    Oncogene; 1998 Mar; 16(12):1579-86. PubMed ID: 9569025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of p53 transcriptional activity by the HPV E7 proteins.
    Massimi P; Banks L
    Virology; 1997 Jan; 227(1):255-9. PubMed ID: 9007083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.
    Helt AM; Galloway DA
    J Virol; 2001 Aug; 75(15):6737-47. PubMed ID: 11435552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of domains required for transcriptional activation and protein dimerization in the human papillomavirus type-16 E7 protein.
    Zwerschke W; Joswig S; Jansen-Dürr P
    Oncogene; 1996 Jan; 12(1):213-20. PubMed ID: 8552395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha.
    Barnard P; McMillan NA
    Virology; 1999 Jul; 259(2):305-13. PubMed ID: 10388655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of E7/Rb associations.
    Caldeira S; Dong W; Tommasino M
    Methods Mol Med; 2005; 119():363-79. PubMed ID: 16350411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300.
    Bernat A; Avvakumov N; Mymryk JS; Banks L
    Oncogene; 2003 Sep; 22(39):7871-81. PubMed ID: 12970734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the FHL2 transcriptional coactivator as a new functional target of the E7 oncoprotein of human papillomavirus type 16.
    Campo-Fernández B; Morandell D; Santer FR; Zwerschke W; Jansen-Dürr P
    J Virol; 2007 Jan; 81(2):1027-32. PubMed ID: 17093190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral interaction: a possible contributing factor in head and neck cancer progression.
    Underbrink MP; Hoskins SL; Pou AM; Albrecht T
    Acta Otolaryngol; 2008; 128(12):1361-9. PubMed ID: 18607925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHES1/FOXN3 interacts with Ski-interacting protein and acts as a transcriptional repressor.
    Scott KL; Plon SE
    Gene; 2005 Oct; 359():119-26. PubMed ID: 16102918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells.
    Banks L; Edmonds C; Vousden KH
    Oncogene; 1990 Sep; 5(9):1383-9. PubMed ID: 2216461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of the fork head domain transcription factor MPP2 with the human papilloma virus 16 E7 protein: enhancement of transformation and transactivation.
    Lüscher-Firzlaff JM; Westendorf JM; Zwicker J; Burkhardt H; Henriksson M; Müller R; Pirollet F; Lüscher B
    Oncogene; 1999 Oct; 18(41):5620-30. PubMed ID: 10523841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity.
    Massimi P; Pim D; Banks L
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2607-13. PubMed ID: 9349482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.